Soluble Therapeutics, LLC

Soluble Bioscience, LLC seeks to enhance the drug discovery process by rapidly optimizing protein solubility and stability.

Founded in 2008 in Birmingham, Alabama, Soluble Bioscience, LLC was formed to commercialize the HSCTM Technology. This system will enhance and speed the research, development and production of protein-based therapeutics, vaccines and research tools that will improve the quality of life and overall state of public health. 

Soluble works with major leading global pharmaceutical companies and leading CROs to significantly reduce the time and costs required to solubalize proteins for their drug development, vaccine and biotech programs.

Soluble Therapeutics was acquired by Cyto Bioscience (formerly Cytocentrics) in November 2016 and renamed Soluble Bioscience.

Soluble Therapeutics, HSCTM Technology